GlaxoSmithKline Says Cervarix Is Approved in Australia (Australia)
This article was originally published in PharmAsia News
GlaxoSmithKline announced that Australian regulators have approved its Cervarix cervical cancer vaccine. The vaccine is still awaiting European regulatory approval. In the United States, GSK applied for marketing approval of the vaccine earlier this year and is hoping the Food and Drug Administration will grant it "priority review" status, which would speed the marketing and approval of the vaccine in the United States. (Click here for more - May Require Paid Subscription
You may also be interested in...
A pilot that used RFID tags with 2D barcodes was touted as more effective than using 2D barcodes alone in tracking drugs through the supply chain.
The current pandemic has accelerated the US FDA’s perspective on conducting remote clinical trials. The agency has published an emergency guidance to allow sponsors to continue their work, which a former FDA official says is an indication of where the agency is headed post-COVID-19.
Facing ongoing shortages, the US FDA is allowing most surgical masks to be used as personal protective equipment under a new emergency use authorization.